Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Other financing activities: 2013-2024

Historic Other financing activities for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $14.9 million.

  • Surgery Partners' Other financing activities fell 40000.0% to -$600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 10735.29%. This contributed to the annual value of $14.9 million for FY2024, which is 3868.31% down from last year.
  • Surgery Partners' Other financing activities amounted to $14.9 million in FY2024, which was down 3868.31% from $24.3 million recorded in FY2023.
  • Over the past 5 years, Surgery Partners' Other financing activities peaked at $25.2 million during FY2022, and registered a low of -$28.4 million during FY2021.
  • Its 5-year average for Other financing activities is $8.9 million, with a median of $14.9 million in 2024.
  • As far as peak fluctuations go, Surgery Partners' Other financing activities tumbled by 43411.76% in 2021, and later skyrocketed by 18873.24% in 2022.
  • Over the past 5 years, Surgery Partners' Other financing activities (Annual) stood at $8.5 million in 2020, then crashed by 434.12% to -$28.4 million in 2021, then skyrocketed by 188.73% to $25.2 million in 2022, then decreased by 3.57% to $24.3 million in 2023, then plummeted by 38.68% to $14.9 million in 2024.
  • Its Other financing activities stands at $14.9 million for FY2024, versus $24.3 million for FY2023 and $25.2 million for FY2022.